Join us for the final episode in our podcast series, COVID19 Road to a vaccine.
The American biotech company Moderna has released early data from phase III clinical trials, announcing that its mRNA COVID-19 vaccine has an efficacy level of 94.5%.
In episode 17 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, speaks to Dr Bonnie Henry, the provincial health officer (PHO) for the Province of BC in Canada. As the PHO Bonnie is leading the province’s response to the COVID-19 pandemic. Bonnie has been in this role since the … Continued
Vaccine developers Pfizer and BioNTech have announced preliminary data shows their COVID-19 vaccine is demonstrating 90% effectiveness, with plans to apply for emergency approval to have the vaccine in use by the end of November.